Replies to post #597955 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

I am really surprised that someone who is long still hasn't realized that DCVax-L technology can cover all solid tumors. I mean taking a look at how DCVax-L is produced. It is a process which is completely tumor-independent. As long as loading the dendritic cells with tumor-specific antigens, making them maturate and activate so that they can present antigens and provide stimulating signals to T cells, then job is done.

[Rising_Sun]

Sure NWBO will eventually apply for all solid tumors.
But when? 10 years later????
It can be 1 year, 2 years, 20 years later, etc.
No one in this IHUB MB knows anything about when NWBO will ever apply for solid tumor, period!

Someday in the future, it will happen, but we never know when....
My biggest fear is, if someone else comes up with equivalent or better treatment than DCVax in near future and get approval even before NWBO apply for approval on "SOLID TUMOR".

Then NWBO's market cap is only limited to GBM market.

[biosectinvestor]

They don’t need to apply for all tumors. They just need one approval. You expand the label and options from there under the most recent reforms.

[attilathehunt]

Why wouldn't ultimate approval be for all solid tumors?

There is a history of it working on other solid tumors....

"The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial and, as resources permit, plans to pursue Phase II trials."

Also, compassionate use results on other solid tumors were positive.

So, I believe there is a higher probability that come approval time, it will include other solid tumors.

Now wouldn't that be a surprise!!